HERBERT F. R. PLASS, M.D.
Monoamine-oxidase (MAO) inhibitors have been increasingly prescribed for depression since 1959. Informal estimates state that under current practices 40% of hospitalized psychiatric patients receive them at some time. Many ambulatory patients receive them as well, perhaps a greater total number than patients in institutions. Adverse reactions must be uncommon in view of the great number of treated patients, yet there have been many reports of severe reactions recently.
Tranylcypromine (Parnate®) was recommended about 1960 in the U. S. A. as the most useful of these drugs (1). This compound resembles the sympathomimetic amines in chemical structure. Its ability to potentiate
PLASS HFR. Monoamine-oxidase Inhibitor Reactions Simulating Phenochromocytoma Attacks. Ann Intern Med. ;61:924–927. doi: 10.7326/0003-4819-61-5-924
Download citation file:
Published: Ann Intern Med. 1964;61(5_Part_1):924-927.
Lupus Erythematosus, Rheumatology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use